Romania

Terapia SA

An EMIS Company Report EMIS is a Euromoney Institutional Investor plc company USD 29.95 Industry: Pharmaceutical and Medicine Manufacturing Available in: English & Romanian Format: PDF Download Most recent financial data: 2016 Buy full report

What’s included?

This report extracts all available information about this company from EMIS' database of company information. The Table of Contents on the right indicates the categories of information that will be included in your report upon purchase.

Download a sample report

Company Tear Sheet (locked content will be provided in the purchased report)

Contact Information

Headquarters
124, Fabricii Street
CLUJ-NAPOCA; Cluj; Map
Postal Code: 400632

Tel: +40 264 501 ; +40 264 501
Fax: +40 264 415 ; +40 721 215

Email:
@sunpharma.com

Website:
http://www.sunpharma.com/romania

Company Description
Established in 1921, Terapia is the largest generic pharmaceutical company in Romania with strong brands and a consistent track record of growth. Terapia SA has a large product portfolio and a robust distribution network, including the largest generic sales force in the country. On 8 June 2006, Ranbaxy Laboratories Ltd. announced the completion of acquisition by Ranbaxy Netherlands BV of 96.7% of Terapia SA. After this acquisition, the company was liquidated, saw the establishment of a new company with the trade name of Terapia Ranbaxy, keeping legal name of Terapia SA. Today company become a subsidiary of Sun Pharmaceutical Industries Ltd.
NAICS Industry Classification
Basic Information
Key Executives
Ownership Details
Key Financial Highlights
Financial Performance Charts
Top Competitors

Financial Statements

Annual Statements
Ratios

EMIS Credit Analytics

EMIS Benchmark Score

What this report allows you to do

EMIS company reports provide the data you need to make accurate assessments about businesses you are interested in.

Identify sales opportunities

  • Does the company match your target demographic?
  • Who are the key executives?

Conduct risk assessment

  • Is the company creditworthy?
  • Is it financially stable?

Carry out strategic research

  • Is the company a potential business partner/investment opportunity?
  • What is its financial performance?

You’re in good company

EMIS company reports are used extensively by the world’s biggest companies, financial institutions, professional service companies and universities to assess businesses in emerging markets.

800,000+

company profiles

We have information on both public and private companies across 125 countries.

2,000+

clients

EMIS is the go-to information source on emerging market companies for the world’s most prestigious businesses.

Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.

REQUEST A DEMO
Contact us to learn more about our business solutions.
FOLLOW US
Sign up to our newsletter

Make sure you’re not the last to know by getting the latest insights on emerging markets straight to your inbox.